Skip to main content

Want a detailed portfolio tracker?

Alaunos Therapeutics (TCRT) P/E (2010 - 2026)

Alaunos Therapeutics (TCRT) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Alaunos Therapeutics (TCRT) P/E is -1.14. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Alaunos Therapeutics (TCRT)

YearP/EChange
2026-1.14-26.71%
2025-1.55+138.36%
2024-0.65+39.65%
2023-0.47-86.58%
2022-3.48+16.38%
2021-2.99-55.78%
2020-6.76-4.40%
2019-7.07+37.07%
2018-5.16-52.47%
2017-10.85+151.61%
2016-4.31-51.80%
2015-8.94-45.19%
2014-16.32+150.04%
2013-6.53+59.86%
2012-4.08+13.34%
2011-3.60-97.38%
2010-137.72N/A

Comparison Alaunos Therapeutics (TCRT) P/E with competitors

Alaunos Therapeutics (TCRT) P/E is -1.14.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.15%
NBYStablecoin Development Corp0.00-100.38%
ENLVEnlivex Ltd0.07-106.57%
FGENFibroGen Inc0.24-121.08%
CHRSCoherus Biosciences Inc0.85-174.51%
FBIOFortress Biotech Inc0.95-183.34%
ORMPOramed Pharmaceuticals Inc1.50-231.99%
AGENAgenus Inc3.01-364.29%
INVAInnoviva Inc3.15-376.97%
VXRTVaxart Inc3.55-411.72%
CRMDCorMedix Inc3.63-418.64%
CVACCureVac N.V.4.45-490.40%
GLPGGalapagos NV4.86-526.69%
SRPTSarepta Therapeutics Inc4.88-528.73%
ABEOAbeona Therapeutics Inc5.39-573.11%
ABUSArbutus Biopharma Corp5.60-591.39%
ZVRAZevra Therapeutics Inc5.89-616.99%
SPROSpero Therapeutics Inc6.23-646.96%
CGENCompugen Ltd6.31-654.47%
RIGLRigel Pharmaceuticals6.87-703.48%
SLXNSilexion Therapeutics Corp7.30-740.71%
OMEROmeros Corporation9.26-913.07%
AUPHAurinia Pharmaceuticals Inc9.58-941.71%
PLXProtalix BioTherapeutics Inc10.89-1056.41%
ACADAcadia Pharmaceuticals Inc11.73-1129.96%
TBPHTheravance Biopharma Inc12.26-1176.82%
ADMAAdma Biologics Inc12.42-1190.52%
HRMYHarmony Biosciences Holdings Inc13.82-1313.64%
SABSSAB Biotherapeutics Inc14.14-1341.39%
NAGENiagen Bioscience Inc14.82-1401.27%
INCYIncyte Corp15.82-1489.48%
REGNRegeneron Pharmaceuticals Inc15.86-1492.47%
PBYIPuma Biotechnology Inc17.32-1620.60%
CPRXCatalyst Pharmaceuticals Inc17.44-1631.46%
EXELExelixis Inc17.54-1640.13%
TGTXTG Therapeutics Inc18.97-1765.53%
MDXGMimedx Group Inc20.55-1904.85%
XOMAXOMA Royalty Corp22.87-2108.83%
ARGXArgen X SE24.30-2233.82%
CTMXCytomX Therapeutics Inc24.82-2279.76%
XOMAOXOMA Royalty Corp25.34-2325.75%
HALOHalozyme Therapeutics Inc25.62-2350.24%
XOMAPXOMA Royalty Corp25.67-2354.32%
VRTXVertex Pharmaceuticals Inc27.99-2558.46%
RPRXRoyalty Pharma plc - Class A28.69-2619.30%
SLNOSoleno Therapeutics Inc29.02-2648.09%
ASNDAscendis Pharma A/S30.09-2742.08%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3429.39%
APLSApellis Pharmaceuticals Inc39.02-3526.79%
BMRNBiomarin Pharmaceutical Inc42.21-3806.99%
KRYSKrystal Biotech Inc45.34-4082.01%
ONCBeiGene Ltd69.54-6206.96%
PHARPharming Group N.V.75.03-6688.66%
TECHBio-Techne Corp101.96-9053.86%
VCELVericel Corp109.92-9753.16%
ALNYAlnylam Pharmaceuticals Inc117.96-10459.55%
GMABGenmab140.29-12420.17%
TLXTelix Pharmaceuticals Ltd162.15-14340.07%
CORTCorcept Therapeutics Inc212.86-18792.89%